Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879164 · ClinicalTrials.gov registry record · Early Phase 1
Stellate Ganglion Nerve Block in Treating Women With Hot Flashes
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT00879164: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT00879164 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00879164, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: A stellate ganglion nerve block may help relieve hot flashes in women. PURPOSE: This clinical trial is studying how well a stellate ganglion nerve block works in treating women with hot flashes.
Interventions
- OTHER questionnaire administration
- DRUG bupivacaine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00879164
The ClinicalTrials.gov registry entry for NCT00879164 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which questionnaire administration is the first listed.
NCT00879164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00879164 about?
NCT00879164 is a clinical study titled "Stellate Ganglion Nerve Block in Treating Women With Hot Flashes". RATIONALE: A stellate ganglion nerve block may help relieve hot flashes in women. PURPOSE: This clinical trial is studying how well a stellate ganglion nerve block works in treating women with hot flashes.
What is the current status of trial NCT00879164?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2009-04. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00879164?
The interventions under investigation include: questionnaire administration (OTHER), bupivacaine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00879164?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.